Skip to main content

What the FDA labels say about taking them together

Clobazam and fenfluramine

Fenfluramine's FDA label of October 27, 2025 names clobazam in its drug interactions section; the clobazam labels PlainMeds reads (2) do not name fenfluramine. The fenfluramine label: “DRUG INTERACTIONS Dose adjustment is required for patients taking stiripentol plus clobazam. Strong CYP1A2 or CYP2D6 inhibitors: a dose adjustment is recommended Strong CYP1A2, CYP2B6, or CYP3A4 inducers: it is …”

Check it at the source: the clobazam FDA label on DailyMed (effective March 12, 2024, Lundbeck Pharmaceuticals LLC); the fenfluramine FDA label on DailyMed (effective October 27, 2025, UCB, Inc.).

What does the clobazam label say about fenfluramine?

Clobazam's label (effective March 12, 2024) and its 1 other brand-application label do not name fenfluramine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Onfi), Lundbeck Pharmaceuticals LLC, effective March 12, 2024 (SPL set de03bd69-2dca-459c-93b4-541fd3e9571c), via openFDA; the full label on DailyMed

What does the fenfluramine label say about clobazam?

Fenfluramine label, drug interactions

DRUG INTERACTIONS Dose adjustment is required for patients taking stiripentol plus clobazam. ( 2.2 , 2.3 , 7.1 ) Strong CYP1A2 or CYP2D6 inhibitors: a dose adjustment is recommended ( 2.3 , 7.1 ) Strong CYP1A2, CYP2B6, or CYP3A4 inducers: it is recommended to avoid coadministration with FINTEPLA.

Source: FDA drug label (Fintepla), NDA212102 (Ucb Inc), as published by UCB, Inc., effective October 27, 2025 (SPL set e88f360e-33ad-4cd6-b2de-5ef885857c5d), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Clobazam generic labelers
0Fenfluramine generic labelers
ClobazamFenfluramine
Labeled forn/an/a
Boxed warningYesYes
Pharmacy cost (NADAC)$0.243 per tablet 10 mg tabletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?